[Haemofiltration in terminal renal failure (author's transl)].
The concentrations of low-molecular retention products rise during long-term haemodialysis, without any apparent side effects. The authors, having performed haemofiltration in 18 patients who had been on a chronic dialysis programme, conclude that haemofiltration is generally better tolerated than conventional haemodialysis. Haemofiltration benefitted the majority of dialysis-resistant hypertensives, and it also favourably influenced uraemic polyneuropathy. Indications for haemofiltration are thought to be dialysis-resistant hypertension, severe polyneuropathy, and dialysis intolerance.
D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy; D006977:Hypertension, Renal / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000628:therapy*; D007688:Kidneys, Artificial / Q000295:instrumentation*; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000628:therapy; D014280:Triglycerides / Q000097:blood; D014462:Ultrafiltration
D014280:Triglycerides
Hämofiltration bei terminaler Niereninsuffizienz.